InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（7 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
7
T+90 胜率
100%
T+90 平均收益
+23.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Gorevic Jason N, 首席执行官. Director active across 2 companies, notably Teladoc Health, Inc.. Aggregated, 23 filings have been published. Breakdown: 3 buys · 7 sells. Total volume traded: €4.6m. History available since 4 May 2021. The latest transaction was disclosed on 10 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gorevic Jason N
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
5,000 股@ US$25.91Common StockSEC:0001208500-26-000004:0
标准退出：2026年11月8日 (T+90)
2,000 股@ US$49.1438.8% 占其流量Common StockSEC:0001208500-25-000003:0
标准退出：2025年11月5日 (T+90)
2,435 股@ US$61.61100.0% 占其流量Common StockSEC:0000860748-25-000144:0
2,565 股0Common StockSEC:0000860748-24-000153:0
21,130 股Common StockSEC:0001477449-24-000044:0
5,615 股Common StockSEC:0001477449-23-000101:0
5,614 股Common StockSEC:0001477449-23-000037:0
10,000 股@ US$30.03033.5% 占其流量Common StockSEC:0001477449-23-000016:0
5,614 股Common StockSEC:0001415889-23-009195:0
2,933 股0Common StockSEC:0000860748-23-000101:0
22,040 股@ US$25.9117.0% 占其流量Common StockSEC:0001415889-23-004415:0
22,458 股Common StockSEC:0001415889-23-004099:0
3,000 股@ US$43.00100.0% 占其流量Common StockSEC:0000860748-22-000140:0
标准退出：2022年11月1日 (T+90)
2,525 股0Common StockSEC:0000860748-22-000090:0
16,778 股Common StockSEC:0001179110-22-002053:0
9,103 股Common StockSEC:0001415889-22-002568:0
614 股0Common StockSEC:0000860748-22-000021:0
5,237 股@ US$150.325915.6% 占其流量Common StockSEC:0001179110-21-009877:0
10,000 股@ US$150.116929.1% 占其流量Common StockSEC:0001179110-21-007943:0
1,000 股@ US$161.27213.1% 占其流量Common StockSEC:0001179110-21-007427:0
10,000 股@ US$153.3428.9% 占其流量Common StockSEC:0001179110-21-006211:0
23,067 股@ US$1.670.8% 占其流量Common StockSEC:0001179110-21-005054:0
1,300 股@ US$154.11853.8% 占其流量Common StockSEC:0001179110-21-004948:0
23 条申报中的 23 条
About Gorevic Jason N
As Directeur Général, GOREVIC JASON N has filed 22 disclosures. Across the 22 sampled filings, the recent transactions run from 2021-05-06 to 2025-08-07, with EUR 211166 of purchases and EUR 4313924 of sales, and the most common transaction type is Levée d'options. He is also linked to Teladoc Health, Inc., where the listed role is CHIEF EXECUTIVE OFFICER, and to KEMPER Corp, where the listed role is Director.
